EN
HI

JENBURKT PHARMACEUTICALS Share price

JENBURPH

HealthcareSmall

1000

19.25 (-1.89%)
Last updated on 9 May, 2025 | 15:29 IST
BUYSELL
Today's High

982.65

Today's Low

1013.00

52 Week Low

1375.00

52 Week High

1375.00

The current prices are delayed, login to your account for live prices

Jenburkt Pharmaceuticals Chart

JENBURKT PHARMACEUTICALS Share Key Metrics

Volume
426.00
Market Cap
449.83 CR
LTQ@LTP
3@1000.00
ATP
1001.63
Var Margin
2088
Circuit Range
815.4-1223.1
Delivery %
0
Value
4.27 L
ASM/GSM
No
Market Lot
1

JENBURKT PHARMACEUTICALS Futures & Options

Data Not Found

JENBURKT PHARMACEUTICALS Corporate Actions

DateAgenda
2025-01-28Quarterly Results
DateEvent TypeAgenda
2025-01-28Board MeetingQuarterly Results

JENBURKT PHARMACEUTICALS News

No Data Found

About JENBURKT PHARMACEUTICALS

NSE : 0  
BSE : 524731  
ISIN : INE354A01013  

The Company was originally incorporated as a PrivateLimited Company on 10th June 1985 in the state ofMaharastra Bombay and subsequently converted into a PublicLimited Company on 4th January 1994 and obtainedcertificate of change of name from the Registrar ofCompanies on 31 st January 1994. The Company has been promoted by ''BHUTA'' Family. The Bhutafamily is having interest in various business activitiessuch as manufacturing and marketing of pharmaceuticalformulations trading in Chemicals Textiles etc. Thegroup turnover in the year 1992-93 was Rs. 1616.85 lacs andover Rs. 2000 Lacs (provisional) for the year 1993-94.Now the Company has taken over the existing business of agroup partnership firm i.e. M/s Jenburkt Pharmaceuticalsa going concern which was engaged in the manufacturing andmarketing of pharmaceuticals formulation on Loan Licencebasis under various brand name registered with appropriateauthorities in the name of firm. Brief history of the said partnership firm is as under: M/S Jenburkt Pharmaceuticals was established in the year1984-85 by Mr. Harshad Bhuta along with his brothers.Initially the firm started manufacturing and marketing ofpharmaceuticals formulations under loan and licence basis.Mainly the products under different therapeutic groupnamely nutritional supplement cough syrup-expectorantHaematinic syrup. Initially the firm had launched theirproducts only in Bombay and some parts of MaharashtraGujarat and Madhya Pradesh. Over last Ten years the firmhad successfully launched more than 15 products and it hasexpanded its marketing 10 times to include areas likemetropolitan Delhi Key areas of Uttar Pradesh RajasthanHaryana Karnataka Goa Andhra Pradesh and Kerala. Its field force had consistently grown from 25 to 170people.Jenburkt Products were made available through a wide spreadnetwork of stockists and super stockists through whom theproducts were distributed to thousands of retail chemistoutlets. The firm had a consistent track record of growthand its turnover had increased to Rs. 484 Lacs during 1993-94 from Rs. 39.92 Lacs in the year 1985-86.MAIN OBJECTS OF THE COMPANYTHE MAIN OBJECTS OF THE COMPANY AS PER MEMORANDUM OFASSOCIATION ARE:- 1. To carry on all or any of the business of manufacturersimporters exporters buyers sellers and distributingagents of and dealers in all kinds of patentpharmaceuticals medicinal and medicated preparationspatent medicines drugs herbs and in pharmaceuticalmedicinal proprietary and industrial preparationscompounds and articles of all kinds and chemicalmanufacturers.SUBSIDIARY COMPANYThe company has no subsidiary.

JENBURKT PHARMACEUTICALS Management

NamePosition
Mr. Ashish U Bhuta Chairman & Managing Director
Mr. Dilip H Bhuta WholeTime Director & CFO
Mrs. Hina R Mehta Ind. Non-Executive Director
Mr. Sumit A Thakkar Ind. Non-Executive Director
Mr. Krishnan Subharaman Ind. Non-Executive Director
Read More

JENBURKT PHARMACEUTICALS FAQs

The Buying Price of JENBURKT PHARMACEUTICALS share is NaN For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy JENBURKT PHARMACEUTICALS share to your Choice trading account, or open a Choice Demat account, then add funds, search the company name, select your order type, and place your trade.

The Price-to-earnings (P/E) ratio of JENBURKT PHARMACEUTICALS shares is 14.1. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio JENBURKT PHARMACEUTICALS shares is 2.7. Useful to assess the stock's value relative to its book value.

To assess JENBURKT PHARMACEUTICALS’s valuation compare Sector P/E, P/B which are 37.31 & 4.59 with sector averages, along with growth rates and financial metrics.

The Market Cap of JENBURKT PHARMACEUTICALS is 449.83 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of JENBURKT PHARMACEUTICALS share price is 1375.00 & 730.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.